Conference abstract · 15 Mar 2017
Conference abstractPublished 15 Mar 2017
Intense ultra-regulated pulsed light in the treatment of meibomian gland dysfunction
Director of Ã?rea OftalmolÃ?³gica Avanzada, Spain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lipid deficiency occurs in 76.7% of dry eye patients with a prevalence of meibomian gland dysfunction (MGD) in the majority of eyes. The treatments of MGD have been shown only short-term symptom relief. This suggests that we need more treatment options, one of which is intense pulsed light therapy (IPL). IPL treatment applies Xenon flash lamp to emitting wavelengths of light ranging from 400 to 1200 nm. The initial application of IPL for dry eye patients began in 2002 and from that, different authors have used this technology reporting good results. In our case, we have improved the IPL with a new system called Intense Ultra-Regulated Pulsed Light (IURPL, Thermaeye Ã?®) which generate short pulses with low energy. The aim of his study is to explore the safety and efficacy of intense ultra-regulated pulsed light (IURPL) in MGD eyes. Methods & Methodology: This is a prospective and open label study. 184 eyes of 92 MGD patients were recruited and received 4 consecutive IURPL treatments on day 1, day 7, day 21, and day 45, with a follow up of 6 months. Symptoms were evaluated with OSDI score. Best corrected visual acuity, IOP, conjunctival injection, upper and lower tear meniscus height, TBUT, corneal staining, lid margin and meibomian gland assessments, and meibography were also recorded. Results: Significant improvements were observed in single and total ocular surface symptom scores, TBUT, and conjunctival injection at all the visits after the initial IURPL treatment (P<0.03). Compared to baseline, the signs of eyelid margin, meibomian gland secretion quality, and expressibility were significantly improved at every visit during 6 months after treatments. There was no regional and systemic threat observed in any patient. Conclusion: Intense ultra-regulated pulsed light (IURPL) therapy is a safe and efficient treatment in relieving symptoms and signs of MGD eyes.
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 19 Aug 2021
Intense Pulsed Light (IPL) in the Treatment of Dry Eye Disease and Meibomian Gland Dysfunction
Research article · 26 Sep 2023
Low Level Light Therapy plus Compression of Meibomian Glands for the Treatment of Evaporative Dry Eye
Research article · 10 Aug 2022
The effect of heat treatment on Meibomian Gland Dysfunction
Research article · 2018
Clinical Impression of the Efficacy of Eyelid Warming or Lid Hygiene as Treatment for Meibomian Gland Dysfunction
More from this journal
The newest in Journal of Clinical and Experimental Ophthalmology.
Research article · 6 Oct 2026
Visual performance of wavefront-shaping extended-depth-of-focus intraocular lenses in Japanese eyes after previous laser in situ keratomileusis
Short communication · 30 Aug 2026
Vision Science in the Modern Era: Integrating Neuroscience, Genetics, and Technology
Commentary · 3 Aug 2026
Emerging Frontiers in Experimental Ophthalmology: Innovations and Translational Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Carlos Verges”

